Mission Statement

Preciva follows principles of primary health care as outlined by the WHO and other international bodies.  Developing innovative healthcare products with a socially responsible corporate ethos, Preciva seeks to realize two goals:

      providing access for every woman to accurate cervical screening and diagnosis;

      shifting high-income health care systems to strategies which favor non-interventional
      monitoring of early stage tissue changes instead of preemptive treatment.

In low income countries, financial, geographical, and cultural barriers limit access to cervical cancer screening which results in high rates of easily preventable deaths. In high income countries, intervention at the early precursor stage is common, an approach which has physical, psychological, and financial consequences for patients, communities, and healthcare systems. Preciva addresses both of these challenges through the development of new screening and diagnostic tests which are more accessible, more accurate, and more supportive of patient-centered care.

Preciva’s premise is that sophisticated technology for examining cervical tissue can produce the highest quality results in worldwide settings, independently of existing infrastructure. Preciva products are designed for thoroughness of sampling, accuracy of analysis, simplicity of use, and ease of manufacture. Preciva intends to transform the diagnosis and treatment process so that women are able to make informed decisions based on non-subjective information that they can monitor over time. We seek partnerships with individuals and organizations that share the goals of advancing personal health autonomy and eliminating different standards in health care for rich and poor communities.